UMIN ID: UMIN000054161
Registered date:16/04/2024
Which is better in opioid titration for cancer pain, oral or injection? A systematice review.
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | cancer pain |
Date of first enrollment | 2024/04/16 |
Target sample size | 500 |
Countries of recruitment | Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa |
Study type | Others,meta-analysis etc |
Intervention(s) |
Outcome(s)
Primary Outcome | Duration until achievement of alliviating cancer pain |
---|---|
Secondary Outcome | adverse effects, QOL |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Patients whose pain mainly result from cancer treatment or associated diseases other than cancer. |
Related Information
Primary Sponsor | The university of Tokyo |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Not applicable |
Secondary ID(s) |
Contact
public contact | |
Name | Natsuk Nakagawa |
Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan Japan 1138655 |
Telephone | 0338155411 |
nnakagawautmedsle@yahoo.co.jp | |
Affiliation | The University of Tokyo Hospital Department of pulmonary medicine |
scientific contact | |
Name | Natsuki Nakagawa |
Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan Japan |
Telephone | 0338155411 |
nnakagawa-tky@umin.ac.jp | |
Affiliation | The university of Tokyo hospital Department of respiratory medicine |